Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Latest Updates of Viva Biotech's Portfolio Companies
2024-06-12 19:51
Latest Updates of Viva Biotech's Portfolio Companies
2024-06-12 19:51
2024ASCO|Memorial Sloan Kettering Cancer Center (MSK)'s Prof. Wungki Park Unveils Precision Targeting of TF in Pancreatic Cancer, Signaling ADC Drug Innovations
2024-06-12 19:31
Growth market USA: Exyte plans to create up to 1,000 new jobs in high-tech facility industry
2024-06-12 19:13
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions
2024-06-12 08:00
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma
2024-06-12 02:15
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)
2024-06-11 20:30
Blackmores' Launch of Nutriventia's TurmXTRA™ Based Range Validates Science of Concentrated Turmeric Ingredient
2024-06-11 20:00
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024
2024-06-11 18:00
Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference
2024-06-11 18:00
Chengdu's influence being felt across the world
2024-06-11 16:44
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility
2024-06-11 15:57
ITC final initial determination Ruled in favor of Hugel (no violation of Section 337)
2024-06-11 11:33
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE
2024-06-11 11:25
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024
2024-06-11 08:10
Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting
2024-06-11 08:00
Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond
2024-06-11 08:00
Smartee Successfully Hosts GS Mandibular Repositioning Conference in Spain
2024-06-10 21:19
Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024
2024-06-10 21:09
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024
2024-06-10 20:00
1
55
56
57
58
59
962